Daily Archives: May 22, 2018

Tempus Labs Co-Founder Eric Lefkofsky Is More Than Just A Business Man

The plague of incurable diseases, like cancer and alzheimer’s, is slowly changing its rhythm as we come into 2018. New accessible advanced technology and artificial intelligence is used in the 21st century to help healthcare professionals and scientists better understand these diseases and their genetically based algorithmic patterns. Eric Lefkofsky and his scientific and medical team at Tempus Labs– a Chicago-based technology firm Lefkofsky helped co-found in 2015– is aiming to merge, consolidate and digitize each patient’s health information. Doing so will allow physicians to learn from the data and use it to help future patients. Tempus has established a series of data pipelines to assist in collecting, cleansing and analyzing clinical and molecular data to put pressure on the use of precision medicine techniques.

48-year old Eric Lefkofsky, co-founder of Tempus Labs in Chicago, is one of Chicago’s most influential entrepreneurs. As a University of Michigan alum, Lefkofsky has become a successful businessman, chairman and co-founder of many successful companies. Tempus Labs differs in that it’s meant completely to help aid patients ridden with diseases such as cancer and alzheimer’s. Tempus labs technological research and treatments will allow for advanced medical care and precision medicine practices to better cure such diseases. On top of Tempus Labs, Lefkofsky is on the board of directors at Children’s Memorial Hospital in Chicago, The Art Institute of Chicago, and The Museum of Science and Industry. He’s a practiced professor at educational institutions such as DePaul University Kellstadt Graduate School of Business, and Kellogg School of Management at Northwestern University. He is currently an adjunct professor at the University of Chicago Booth School of Business teaching a course on building technology-based businesses to help better communities.

Lefkofsky has always had first-hand experiences in his communities caring for and teaching youth, patients, and loved ones not just in Chicago, but now throughout the world. The work Tempus Labs is doing will help benefit the entire world through Lefkofsky and his Tempus Labs team’s motive to cure and prevent cancer and alzheimer’s in patients around the globe.

To Read More Click Here